Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Technology has improved insulin delivery devices, which has made managing glucose levels easier. Yet most people who take insulin continue to use a syringe or...
Continuous glucose monitoring coverage varies widely by state Medicaid program – check out our guide on who's covered and where
If you’ve got unused diabetes supplies that you no longer need, don’t throw them away! Here are several easy ways that you can donate your supplies to others.
A study recently published in the New England Journal of Medicine shows that a bionic pancreas, or a closed-loop automated insulin delivery system, kept blood glucose...
The first large-scale launch of the highly anticipated Dexcom G7 continuous glucose monitor (CGM) has officially begun. The next-generation CGM is now available in...
In October 2022, Dexcom announced that its next-generation continuous glucose monitor (CGM), Dexcom G7, is now available to people with diabetes in Hong Kong and several...
Continuous glucose monitors (CGM) are a valuable tool, allowing people with diabetes to stay informed to make decisions without having to constantly prick their fingers...
Results from the Diabetes Technology Society’s Blood Glucose Meter Surveillance Program identifies only six out of 18 meters that passed. Did yours make the cut?
A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...
The Libre Sense CGM is similar to the Freestyle Libre 2, but it’s made for athletes and not for people with diabetes
A recent research study on open-source AID, a method of insulin delivery used by thousands of people with type 1 diabetes, showed that using open-source AID improved...
How this online program is a leader in digital health for programs based on the CDC’s National Diabetes Prevention efforts. Plus, a bonus interview with CEO Sean Duffy!
The Omnipod 5 automated insulin delivery system has been cleared by the FDA for people with type 1 diabetes. The system, which includes a tubeless insulin pump, a Dexcom...
El 27 de julio, Dexcom anunció el lanzamiento de la aplicación móvil Dexcom G6 en español, disponible para cualquier persona con un teléfono inteligente. Los usuarios de...
On July 27, Dexcom announced the launch of the Dexcom G6 mobile app in Spanish, available for anyone with a smartphone. Dexcom CGM users can now choose to view their...
Spinal cord stimulators, a type of implantable device, have been researched as a treatment for painful diabetic neuropathy, a complication of diabetes that leads to...
Earlier this week, Dexcom announced its decision to re-submit the software for the much-anticipated G7, pushing back the US launch date until later in 2022. Here’s why...
diaTribe’s Julie Heverly had the opportunity to try the new Tandem mobile app, which allows users to administer insulin boluses directly from their smartphones. Here’s...
A fully virtual six-month clinical trial is recruiting 300 people with type 1 and type 2 diabetes who are interested in trying continuous glucose monitoring (CGM) with...
Automated insulin delivery (AID) systems have helped many people with diabetes improve their glucose management and Time in Range, both during the day and overnight...

Pages